{"entity":{"id":"nct04343274","kind":"trial","name":"Expanded Access for BLZ-100 (Tozuleristide)","aka":[],"tldr":"An trial of Tozuleristide run by Blaze Bioscience Inc., registered.","summary":"Expanded Access for BLZ-100 (Tozuleristide) is an interventional study registered as NCT04343274 by Blaze Bioscience Inc.. Conditions recorded: not stated. Interventions recorded: Tozuleristide.","status":"active","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT04343274","url":"https://clinicaltrials.gov/study/NCT04343274"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":["blz-100"],"companies":["blaze-bioscience"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT04343274","phase":"not-applicable","setting":"Expanded Access for BLZ-100 (Tozuleristide)","sponsor":"Blaze Bioscience Inc.","enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct04343274/","neighbours":{"drug":[{"id":"blz-100","kind":"drug","name":"Tozuleristide","route":"/drugs/blz-100/"}],"company":[{"id":"blaze-bioscience","kind":"company","name":"Blaze Bioscience","route":"/companies/blaze-bioscience/"}]}}